title: Role of purinergic cotransmission in the sympathetic control of arterial pressure variability in conscious rats.
abstract: Previous studies have shown that the sympathetically mediated oscillations of arterial pressure (AP), the so-called Mayer waves, are shifted from 0.4 to 0.6 Hz after acute alpha-adrenoceptor blockade in conscious rats. This raises the possibility that, under physiological conditions, Mayer waves are mediated by the conjoint action of norepinephrine and other sympathetic cotransmitters. To evaluate the possible role of the cotransmitter ATP in determining the frequency of Mayer waves, AP and renal sympathetic nerve activity (RSNA) were simultaneously recorded in 10 conscious rats with cardiac autonomic blockade before and after acute blockade of P2 receptors with pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid. P2 receptor blockade did not alter the mean level and overall variability of AP and RSNA but shifted peak coherence between AP and RSNA from 0.43 +/- 0.02 to 0.22 +/- 0.01 Hz. A model of the sympathetic limb of the arterial baroreceptor reflex was designed to simulate Mayer waves at 0.2 and 0.6 Hz, with norepinephrine and ATP, respectively, acting as the sole sympathetic cotransmitter. When both cotransmitters acted in concert, a single oscillation was observed at 0.4 Hz when the gain ratio of the adrenergic to the purinergic components was set at 15. The model thus accounted for an important role for ATP in determining Mayer wave frequency, but not in sustaining the mean level of AP or controlling its overall variability.
authors.affiliation: Département de Physiologie et Pharmacologie Clinique, Université Lyon, 69373 Lyon Cedex 08, France.
authors.forename: Léa
authors.initials: L
authors.lastname: Emonnot
authors.forename: Charles
authors.initials: C
authors.lastname: Bakhos
authors.forename: Bruno
authors.initials: B
authors.lastname: Chapuis
authors.forename: Valérie
authors.initials: V
authors.lastname: Oréa
authors.forename: Christian
authors.initials: C
authors.lastname: Barrès
authors.forename: Claude
authors.initials: C
authors.lastname: Julien
mesh_terms: D000320:Adrenergic Fibers / Q000502:physiology; D000818:Animals; D001794:Blood Pressure / Q000502:physiology*; D007668:Kidney / Q000294:innervation; D008297:Male; D058919:Purinergic P2 Receptor Antagonists; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018048:Receptors, Purinergic P2 / Q000378:metabolism*
chemical_list: D058919:Purinergic P2 Receptor Antagonists; D018048:Receptors, Purinergic P2; C077792:pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid; D011732:Pyridoxal Phosphate